Skip to main content
. 2019 Aug 15;16(1):86–94. doi: 10.1080/21645515.2019.1633877

Table 3.

Geometric Mean Titer (GMT) and Haemagglutination inhibition (HI) antibody responses (seroprotection and seroconversion) against seasonal influenza strains in children and adolescents with type 1 diabetes (T1D) vaccinated with inactivated quadrivalent influenza vaccine (QIV) according to assumption (Probiotic group) or not (Control group) of Lactobacillus rhamnosus GG.

  Time Probiotic group Control group
A/Michigan (HIN1)
GMT T1 49.1 42.9
  T2 434.5*** 463.1***
GMTR T1    
  T2 8.8 10.8
Protected, n. (%) T1 23 (67.6) 16 (53.3)
  T2 32 (94.1)* 30 (100)***
Seroconversion, n. (%) T1    
  T2 27 (79.4) 20 (66.7)
A/HongKong (H3N2)
GMT T1 147.5 171.5
  T2 471.4*** 557.2***
GMTR T1    
  T2 3.2 3.2
Protected, n. (%) T1 33 (97.1) 28 (93.3)
  T2 34 (100) 30 (100)
Seroconversion, n. (%) T1    
  T2 15 (44.1) 14 (46.7)
B/Brisbane (victoria-like)
GMT T1 33.9 54.1
  T2 204.3*** 206.3***
GMTR T1    
  T2 6.0 3.8
Protected, n. (%) T1 21 (61.8) 21 (70.0)
  T2 31 (91.2)** 27 (90.0)
Seroconversion, n. (%) T1    
  T2 23 (67.6) 17 (56.7)
B/Phuket (yamagata-like)
GMT T1 13.3 17.8
  T2 69.4*** 85.7***
GMTR T1    
  T2 5.2 4.8
Protected, n. (%) T1 10 (29.4) 12 (40.0)
  T2 26 (76.5)*** 25 (83.3)***
Seroconversion, n. (%) T1    
  T2 19 (55.9) 14 (46.7)

GMT: Geometric Mean Titer; GMTR: Geometric Mean Titer Ratio.

Differences in GMT and seroprotection frequency between T1 and T2 within each group were compared using the Wilcoxon rank-sum tests or Fisher’s exact test as appropriate. *P < 0.05, **P < 0.01, and ***P < 0.001; NS.